A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
ORTHOPEDIATRICS CORP
KIDS
$443M
Mkt Cap
$18.87
+0.80%
ORTHOPEDIATRICS CORP (KIDS) has a 5-year average return on invested capital (ROIC) of -6.1%. This is below average and may indicate limited pricing power.
ORTHOPEDIATRICS CORP (KIDS) has a market capitalization of $483M. It is classified as a small-cap stock.
ORTHOPEDIATRICS CORP (KIDS) does not currently pay a regular dividend.
ORTHOPEDIATRICS CORP (KIDS) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
ORTHOPEDIATRICS CORP (KIDS) reported annual revenue of $236 million in its most recent fiscal year, based on SEC EDGAR filings.
ORTHOPEDIATRICS CORP (KIDS) has a net profit margin of -16.8%. The company is currently unprofitable.
ORTHOPEDIATRICS CORP (KIDS) generated $-16 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
OrthoPediatrics Corp. (the "Company") is a Delaware corporation, headquartered in Warsaw, Indiana, and organized in November 2007. The Company’s Common Stock is traded on the Nasdaq Global Market under the symbol KIDS. OrthoPediatrics Corp. is a medical device company committed to designing, developing and marketing anatomically appropriate implants, instruments and specialized braces for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers the ability to treat children with technologies specifically designed to meet their needs. Initially organized as an Indiana limited liability company on August 31, 2006, OrthoPediatrics Corp. was converted to a Delaware corporation on November 30, 2007.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 243M | 236M | 205M | 149M | 122M | 98M |
| Net Income | -40M | -40M | -38M | -21M | 1.2M | -16M |
| EPS | $-1.57 | $-1.69 | $-1.64 | $-0.92 | $0.06 | $-0.84 |
| Free Cash Flow | -13M | -16M | -41M | -44M | -32M | -21M |
| ROIC | -7.4% | -9.1% | -9.3% | -5.5% | 0.4% | -7.0% |
| Gross Margin | 73.1% | 73.1% | 72.6% | 74.8% | 74.1% | 74.9% |
| Debt/Equity | 0.30 | 0.33 | 0.23 | 0.03 | 0.00 | 0.00 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -37M | -39M | -35M | -27M | -25M | -18M |
| Operating Margin | -15.0% | -16.6% | -17.1% | -18.0% | -20.8% | -18.4% |
| ROE | -11.7% | -11.3% | -10.3% | -5.6% | 0.4% | -7.1% |
| Shares Outstanding | 26M | 23M | 23M | 23M | 21M | 19M |
| Metric | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | 31M | 37M | 46M | 58M | 73M | 71M | 98M | 122M | 149M | 205M | 236M | 243M |
| Gross Margin | 69.8% | 70.7% | 75.5% | 74.2% | 75.3% | 77.4% | 74.9% | 74.1% | 74.8% | 72.6% | 73.1% | 73.1% |
| R&D | 1.8M | 2.2M | 3.4M | 4.7M | 5.7M | 5.3M | 5.5M | 8.5M | 11M | 11M | 9.1M | 9.0M |
| SG&A | 11M | 12M | 17M | 21M | 27M | 38M | 46M | 58M | 73M | 103M | 120M | 121M |
| EBIT | -6.6M | -6.1M | -6.5M | -9.6M | -9.1M | -27M | -18M | -25M | -27M | -35M | -39M | -37M |
| Op. Margin | -21.3% | -16.4% | -14.2% | -16.6% | -12.5% | -37.6% | -18.4% | -20.8% | -18.0% | -17.1% | -16.6% | -15.0% |
| Net Income | -13M | -12M | -24M | -12M | -14M | -33M | -16M | 1.2M | -21M | -38M | -40M | -40M |
| Net Margin | -40.9% | -33.4% | -51.6% | -20.9% | -18.9% | -46.3% | -16.6% | 1.0% | -14.1% | -18.5% | -16.8% | -16.3% |
| Non-Recurring | 303K | 219K | 344K | 504K | 394K | 1.3M | 1.1M | 0 | 0 | 3.7M | 7.5M | 5.6M |
| Returns on Capital | ||||||||||||
| ROIC | N/A | -20.0% | -11.5% | -13.7% | -10.1% | -16.3% | -7.0% | 0.4% | -5.5% | -9.3% | -9.1% | -7.4% |
| ROE | 26.2% | 20.8% | 264.2% | -18.6% | -12.3% | -17.5% | -7.1% | 0.4% | -5.6% | -10.3% | -11.3% | -11.7% |
| ROA | N/A | -81.1% | -41.7% | -12.4% | -9.3% | -13.1% | -5.2% | 0.3% | -4.8% | -8.3% | -8.1% | -7.9% |
| Cash Flow | ||||||||||||
| Op. Cash Flow | -892K | -1.1M | -7.2M | -16M | -18M | -19M | -13M | -22M | -27M | -27M | -4.9M | -4.0M |
| Free Cash Flow | -3.1M | -5.5M | -12M | -21M | -30M | -29M | -21M | -32M | -44M | -41M | -16M | -13M |
| Owner Earnings | -4.0M | -4.3M | -13M | -22M | -25M | -33M | -30M | -42M | -55M | -60M | -44M | -44M |
| CapEx | 2.2M | 4.3M | 5.2M | 5.3M | 12M | 11M | 8.1M | 10M | 17M | 14M | 11M | 8.6M |
| Maint. CapEx | 1.9M | 1.9M | 2.4M | 2.9M | 4.7M | 8.0M | 11M | 13M | 17M | 19M | 21M | 22M |
| Growth CapEx | 357K | 2.4M | 2.8M | 2.4M | 7.1M | 2.5M | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 1.9M | 1.9M | 2.4M | 2.9M | 4.7M | 8.0M | 11M | 13M | 17M | 19M | 21M | 22M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||||||||
| Dividends Paid | 0 | 0 | 6.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | 2.5% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.0% |
| Stock-Based Comp | 1.2M | 1.3M | 3.5M | 3.2M | 2.6M | 6.2M | 5.8M | 6.7M | 11M | 14M | 18M | 18M |
| Debt Repayment | 98K | 102K | 78K | 113K | 0 | 0 | 0 | 0 | 0 | 12M | 0 | 0 |
| Balance Sheet | ||||||||||||
| Net Debt | -3.9M | 20M | -13M | -39M | -45M | -83M | -52M | -117M | -69M | 13M | 53M | 54M |
| Cash & Equiv. | 3.9M | 1.6M | 43M | 61M | 71M | 29M | 7.6M | 9.0M | 31M | 44M | 20M | 49M |
| Long-Term Debt | 0 | 17M | 25M | 21M | 26M | 1.0M | 907K | 763K | 9.9M | 73M | 100M | 100M |
| Debt/Equity | 0.00 | -0.34 | 0.62 | 0.26 | 0.18 | 0.01 | 0.00 | 0.00 | 0.03 | 0.23 | 0.33 | 0.30 |
| Interest Coverage | -5.4 | -4.2 | -2.6 | -4.2 | -2.6 | -7.8 | -321.9 | -48.4 | -636.9 | -1000.3 | -1453.3 | -1453.3 |
| Equity | -54M | -65M | 47M | 82M | 142M | 235M | 225M | 379M | 377M | 355M | 347M | 339M |
| Total Assets | N/A | 31M | 82M | 112M | 182M | 320M | 304M | 428M | 439M | 473M | 509M | 502M |
| Total Liabilities | N/A | 25M | 35M | 30M | 40M | 86M | 79M | 49M | 62M | 119M | 162M | 163M |
| Intangibles | N/A | 1.3M | 2.3M | 2.2M | 14M | 50M | 55M | 65M | 69M | 64M | 65M | 64M |
| Retained Earnings | N/A | -78M | -103M | -115M | -129M | -162M | -178M | -177M | -198M | -236M | -275M | -286M |
| Working Capital | N/A | 14M | 60M | 88M | 114M | 123M | 104M | 196M | 185M | 203M | 210M | 199M |
| Current Assets | N/A | 21M | 70M | 97M | 128M | 158M | 134M | 227M | 226M | 237M | 256M | 246M |
| Current Liabilities | N/A | 7.3M | 9.5M | 9.2M | 14M | 35M | 30M | 31M | 42M | 34M | 46M | 47M |
| Per Share Data | ||||||||||||
| EPS | -7.27 | -7.14 | -1.86 | -0.96 | -0.94 | -1.82 | -0.84 | 0.06 | -0.92 | -1.64 | -1.69 | -1.57 |
| Owner EPS | -2.28 | -2.45 | -1.04 | -1.73 | -1.71 | -1.81 | -1.53 | -2.02 | -2.41 | -2.59 | -1.86 | -1.71 |
| Book Value | -31.01 | -37.46 | 3.76 | 6.52 | 9.75 | 12.97 | 11.64 | 18.40 | 16.54 | 15.37 | 14.77 | 13.23 |
| Cash Flow/Share | -0.51 | -0.64 | -0.57 | -1.24 | -1.22 | -1.02 | -0.67 | -1.06 | -1.19 | -1.17 | -0.21 | -0.70 |
| Dividends/Share | 0.00 | 0.00 | 0.47 | 0.00 | 0.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 1.7M | 1.7M | 12.6M | 12.5M | 14.6M | 18.1M | 19.4M | 20.6M | 22.8M | 23.1M | 23.5M | 25.6M |
| Valuation | ||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 612.2 | N/A | N/A | N/A | -12.0 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | 5.8 | 5.2 | 4.8 | 3.6 | 5.3 | 2.0 | 2.0 | 1.5 | N/A | 1.4 |
| Price/Sales | N/A | N/A | 6.1 | 5.5 | 7.6 | 11.6 | 11.5 | 8.1 | 6.0 | 3.2 | N/A | 2.0 |
| FCF Yield | N/A | N/A | -4.5% | -4.9% | -4.4% | -3.4% | -1.8% | -4.1% | -5.8% | -7.8% | N/A | -2.6% |
| Market Cap | 0 | N/A | 274M | 429M | 679M | 851M | 1.2B | 770M | 762M | 528M | 0 | 483M |
| Avg. Price | 0.00 | N/A | 19.12 | 25.30 | 37.83 | 45.55 | 58.05 | 47.15 | 39.42 | 28.54 | 0.00 | 18.87 |
| Year-End Price | 0.00 | N/A | 18.84 | 34.22 | 46.50 | 47.00 | 61.34 | 36.73 | 33.42 | 22.89 | 0.00 | 18.87 |
ORTHOPEDIATRICS CORP passes 3 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 73.9%.
ORTHOPEDIATRICS CORP (KIDS) has a debt-to-equity ratio of 0.33. This indicates a conservatively financed balance sheet.
ORTHOPEDIATRICS CORP (KIDS) reported earnings per share (EPS) of $-1.69 in its most recent fiscal year.
ORTHOPEDIATRICS CORP (KIDS) has a return on equity (ROE) of -11.3%. A negative ROE may indicate losses or negative equity.
ORTHOPEDIATRICS CORP (KIDS) has a 5-year average gross margin of 73.9%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 11 years of financial data for ORTHOPEDIATRICS CORP (KIDS), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
ORTHOPEDIATRICS CORP (KIDS) has a book value per share of $14.77, based on its most recent annual SEC filing.